血管性水肿：度普利尤单抗治疗特应性皮炎时的一种潜在并发症。
Angioedema: A potential complication of dupilumab in atopic dermatitis.
作者信息
Fritz Andrea L, Lacy Frank A, Morrell Dean S
机构信息
Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA.
出版信息
Pediatr Dermatol. 2021 Jan;38(1):237-238. doi: 10.1111/pde.14434. Epub 2020 Oct 25.
PMID:33099796
Abstract
Dupilumab is a relatively new and quite effective medication for recalcitrant atopic dermatitis in patients over 6 years of age. Here, we present a 12-year-old girl with progressively worsening episodic facial swelling and erythema while treated with dupilumab. This case highlights the possibility of angioedema as an adverse effect of dupilumab treatment.
摘要
度普利尤单抗是一种相对较新且对6岁以上顽固性特应性皮炎相当有效的药物。在此，我们报告一名12岁女孩，在接受度普利尤单抗治疗期间出现面部肿胀和红斑进行性加重。该病例突出了血管性水肿作为度普利尤单抗治疗不良反应的可能性。
Zotero 插件